Cytek Biosciences Files 8-K on Shareholder Vote Matters

Ticker: CTKB · Form: 8-K · Filed: Jun 11, 2024 · CIK: 1831915

Cytek Biosciences, Inc. 8-K Filing Summary
FieldDetail
CompanyCytek Biosciences, Inc. (CTKB)
Form Type8-K
Filed DateJun 11, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, shareholder-vote

TL;DR

Cytek held a shareholder vote on June 5th, filed the 8-K on June 11th.

AI Summary

Cytek Biosciences, Inc. filed an 8-K on June 11, 2024, reporting on matters submitted to a vote of security holders on June 5, 2024. The filing details the company's corporate structure and reporting information, including its principal executive offices in Fremont, California.

Why It Matters

This filing is a routine update for investors, confirming that the company has addressed matters requiring a vote from its security holders.

Risk Assessment

Risk Level: low — This is a standard regulatory filing and does not indicate any new or unusual risks for the company.

Key Players & Entities

  • Cytek Biosciences, Inc. (company) — Registrant
  • June 5, 2024 (date) — Date of earliest event reported
  • June 11, 2024 (date) — Date of Report
  • Fremont, California (location) — Principal executive offices

FAQ

What specific matters were submitted to a vote of Cytek Biosciences' security holders on June 5, 2024?

The filing states that matters were submitted to a vote of security holders on June 5, 2024, but does not specify the exact nature of these matters within the provided text.

When was the 8-K filing submitted to the SEC?

The 8-K filing was submitted on June 11, 2024.

What is the principal executive office address for Cytek Biosciences, Inc.?

The principal executive offices are located at 47215 Lakeview Boulevard, Fremont, California 94538.

What is the IRS Employer Identification Number for Cytek Biosciences, Inc.?

The IRS Employer Identification Number is 47-2547526.

What is the SEC file number for Cytek Biosciences, Inc.?

The SEC file number is 001-40632.

Filing Stats: 617 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-06-11 16:02:53

Key Financial Figures

  • $0.001 — ich registered Common Stock, par value $0.001 per share CTKB Nasdaq Global Select

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cytek Biosciences, Inc. Date: June 11, 2024 By: /s/ Wenbin Jiang, Ph.D. Wenbin Jiang, Ph.D. President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.